BioAcyl Corp
BioAcyl Corp |
|
 |
 |
 |
|
Liu, Y., Zhou, T., & Hu, J. (2022). Targeting selective autophagy as a therapeutic strategy for viral infectious diseases. Frontiers in Microbiology, 13. Added by: Dr. Enrique Feoli (11/11/2022, 20:14) Last edited by: Dr. Enrique Feoli (11/11/2022, 20:16) |
 |
| Resource type: Journal Article DOI: 10.3389/fmicb.2022.889835 ID no. (ISBN etc.): 1664-302X BibTeX citation key: Liu2022 View all bibliographic details  |
Categories: BioAcyl Corp Subcategories: Autophagy and mitophagy Creators: Hu, Liu, Zhou Collection: Frontiers in Microbiology |
Views: 2/124
|
| Abstract |
|
Autophagy is an evolutionarily conserved lysosomal degradation system which can recycle multiple cytoplasmic components under both physiological and stressful conditions. Autophagy could be highly selective to deliver different cargoes or substrates, including protein aggregates, pathogenic proteins or superfluous organelles to lysosome using a series of cargo receptor proteins. During viral invasion, cargo receptors selectively target pathogenic components to autolysosome to defense against infection. However, viruses not only evolve different strategies to counteract and escape selective autophagy, but also utilize selective autophagy to restrict antiviral responses to expedite viral replication. Furthermore, several viruses could activate certain forms of selective autophagy, including mitophagy, lipophagy, aggrephagy, and ferritinophagy, for more effective infection and replication. The complicated relationship between selective autophagy and viral infection indicates that selective autophagy may provide potential therapeutic targets for human infectious diseases. In this review, we will summarize the recent progress on the interplay between selective autophagy and host antiviral defense, aiming to arouse the importance of modulating selective autophagy as future therapies toward viral infectious diseases.
|